Stay updated with breaking news from Nasdaq Aktx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com began coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Free Report) in a report published on Thursday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Akari Therapeutics Price Performance AKTX opened at $1.36 on Thursday. The stock’s 50 day moving average price is $1.69 and its 200-day moving average price is […]
StockNews.com began coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Free Report) in a research report report published on Tuesday morning. The firm issued a sell rating on the biopharmaceutical company’s stock. Akari Therapeutics Stock Performance AKTX stock opened at $1.17 on Tuesday. Akari Therapeutics has a 1 year low of $1.08 and a 1 […]
Akari Therapeutics, Plc (NASDAQ:AKTX – Get Free Report) was the target of a large increase in short interest during the month of March. As of March 31st, there was short interest totalling 10,500 shares, an increase of 75.0% from the March 15th total of 6,000 shares. Approximately 0.2% of the shares of the stock are […]
StockNews.com started coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Free Report) in a report issued on Saturday. The firm issued a sell rating on the biopharmaceutical company’s stock. Akari Therapeutics Trading Up 4.4 % Shares of NASDAQ AKTX opened at $1.89 on Friday. Akari Therapeutics has a 1 year low of $1.66 and a […]
Akari Therapeutics, Plc (NASDAQ:AKTX – Get Free Report) saw a large decline in short interest in January. As of January 31st, there was short interest totalling 1,900 shares, a decline of 66.7% from the January 15th total of 5,700 shares. Approximately 0.0% of the shares of the stock are sold short. Based on an average […]